Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
38
JKHY Quote, Financials, Valuation and Earnings
Last price:
$176.75
Seasonality move
:
9.74%
Day range:
$174.96 - $178.40
52-week range:
$157.00 - $189.63
Dividend yield:
1.25%
P/E ratio:
32.35x
P/S ratio:
5.75x
P/B ratio:
6.70x
Volume:
862.5K
Avg. volume:
700.2K
1-year change:
8.5%
Market cap:
$12.9B
Revenue:
$2.2B
EPS (TTM):
$5.46
Earnings Data
Next earnings date for JKHY
Feb 06
2025
Most recent earnings per share
$1.63
Beat by $0.03
(Nov 5/2024)
Consensus Estimate
$1.60
(Nov 5/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
JKHY Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/06/2025 | Q4 | $577.5M | -- | -- | $1.32 | -- |
| 11/05/2024 | Q3 | $599.7M | $601M | $1.63 | $1.60 | $0.03 |
| 08/20/2024 | Q2 | $563.1M | $559.9M | $1.38 | $1.30 | $0.08 |
| 05/07/2024 | Q1 | $541.1M | $538.6M | $1.19 | $1.16 | $0.03 |
| 02/06/2024 | Q4 | $540.7M | $545.7M | $1.26 | $1.13 | $0.13 |
| 11/07/2023 | Q3 | -- | -- | $1.39 | $1.33 | $0.06 |
| 08/15/2023 | Q2 | -- | -- | $1.34 | $1.18 | $0.16 |
| 05/02/2023 | Q1 | -- | -- | $1.12 | $1.10 | $0.02 |
| 02/07/2023 | Q4 | -- | -- | $1.10 | $1.11 | -$0.01 |
| 11/08/2022 | Q3 | -- | -- | $1.46 | $1.40 | $0.06 |
| 08/16/2022 | Q2 | -- | -- | $1.10 | $1.00 | $0.10 |
| 05/03/2022 | Q1 | -- | -- | $1.16 | $1.06 | $0.10 |
| 02/08/2022 | Q4 | -- | -- | $1.30 | $1.12 | $0.18 |
| 11/08/2021 | Q3 | -- | -- | $1.38 | $1.32 | $0.06 |
| 08/17/2021 | Q2 | -- | -- | $1.04 | $0.92 | $0.11 |
| 05/03/2021 | Q1 | -- | -- | $0.95 | $0.85 | $0.10 |
| 02/08/2021 | Q4 | -- | -- | $0.94 | $0.87 | $0.07 |
| 11/04/2020 | Q3 | -- | -- | $1.19 | $1.05 | $0.14 |
| 08/18/2020 | Q2 | -- | -- | $0.80 | $0.78 | $0.02 |
| 05/04/2020 | Q1 | -- | -- | $0.96 | $0.80 | $0.16 |
| 02/04/2020 | Q4 | -- | -- | $0.94 | $0.89 | $0.05 |
| 11/04/2019 | Q3 | -- | -- | $1.16 | $1.04 | $0.12 |
| 08/20/2019 | Q2 | -- | -- | $0.79 | $0.77 | $0.02 |
| 04/30/2019 | Q1 | -- | -- | $0.77 | $0.76 | $0.01 |
| 02/05/2019 | Q4 | -- | -- | $0.88 | $0.85 | $0.03 |
| 11/06/2018 | Q3 | -- | -- | $1.08 | $0.94 | $0.14 |
| 08/21/2018 | Q2 | -- | -- | $1.10 | -- | -- |
| 05/01/2018 | Q1 | -- | -- | $0.89 | -- | -- |
| 02/06/2018 | Q4 | -- | -- | $2.08 | -- | -- |
| 11/07/2017 | Q3 | -- | -- | $0.86 | -- | -- |
| 08/15/2017 | Q2 | -- | -- | $0.83 | -- | -- |
| 05/02/2017 | Q1 | -- | -- | $0.77 | -- | -- |
| 02/07/2017 | Q4 | -- | -- | $0.75 | -- | -- |
| 11/07/2016 | Q3 | -- | -- | $0.79 | -- | -- |
| 08/17/2016 | Q2 | -- | -- | $1.06 | -- | -- |
| 05/04/2016 | Q1 | -- | -- | $0.68 | -- | -- |
| 02/02/2016 | Q4 | -- | -- | $0.74 | -- | -- |
| 11/05/2015 | Q3 | -- | -- | $0.64 | -- | -- |
| 08/25/2015 | Q2 | -- | -- | $0.75 | -- | -- |
| 05/06/2015 | Q1 | -- | -- | $0.63 | -- | -- |
| 02/03/2015 | Q4 | -- | -- | $0.66 | -- | -- |
Jack Henry & Associates Earnings Questions
-
How Much did Jack Henry & Associates Generate in Revenue Last Quarter?
Jack Henry & Associates reported $601M worth of top line sales in its most recent quarter.
-
Did Jack Henry & Associates Beat Earnings Last Quarter?
Jack Henry & Associates announced earnings per share of $1.63 which represents a beat of analyst forecast a $1.60 per share.
-
Is Jack Henry & Associates Profitable?
Jack Henry & Associates reported $257.6M that represents $3.52 per share over the last quarter.
-
What is the Analyst Consensus for Jack Henry & Associates EPS Next Year?
Jack Henry & Associates's earnings are forecast to grow from $5.23 per share to $5.23 per share next year representing an increase of 10.2%.
-
When is Jack Henry & Associates's Earnings Date?
Jack Henry & Associates's next earnings date is February 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
